Cargando…
An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants
A pro-inflammatory intestinal microbiome is characteristic of Parkinson’s disease (PD). Prebiotic fibers change the microbiome and this study sought to understand the utility of prebiotic fibers for use in PD patients. The first experiments demonstrate that fermentation of PD patient stool with preb...
Autores principales: | Hall, Deborah A., Voigt, Robin M., Cantu-Jungles, Thaisa M., Hamaker, Bruce, Engen, Phillip A., Shaikh, Maliha, Raeisi, Shohreh, Green, Stefan J., Naqib, Ankur, Forsyth, Christopher B., Chen, Tingting, Manfready, Richard, Ouyang, Bichun, Rasmussen, Heather E., Sedghi, Shahriar, Goetz, Christopher G., Keshavarzian, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938693/ https://www.ncbi.nlm.nih.gov/pubmed/36801916 http://dx.doi.org/10.1038/s41467-023-36497-x |
Ejemplares similares
-
Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease
por: Cantu-Jungles, Thaisa M., et al.
Publicado: (2019) -
Single-Arm, Non-randomized, Time Series, Single-Subject Study of Fecal Microbiota Transplantation in Multiple Sclerosis
por: Engen, Phillip A., et al.
Publicado: (2020) -
Attenuated Postprandial GLP-1 Response in Parkinson’s Disease
por: Manfready, Richard A., et al.
Publicado: (2021) -
Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease
por: Jackson, Aeja, et al.
Publicado: (2022) -
Gut microbial metabolites in Parkinson’s disease: Association with lifestyle, disease characteristics, and treatment status
por: Voigt, Robin M., et al.
Publicado: (2022)